KIORA PHARMACEUTICALS INC (KPRX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-02

KIORA PHARMACEUTICALS INC (KPRX) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 3 Form 8-K material event filings were reported by KPRX in the last 90 days. InsiderAlpha tracks every KPRX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About KIORA PHARMACEUTICALS INC (KPRX)

SEC CIK	0001372514

90-Day SEC Filing Activity

Form 4 filings (90d)	8
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-07-02

Recent KPRX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-07-01	Tosca Melissa	CFO	F — Tax withholding / forfeiture	911	$2.66	$2K	SEC
2026-07-01	Strem Brian M.	President and CEO	F — Tax withholding / forfeiture	1.9K	$2.66	$5K	SEC
2026-04-01	Tosca Melissa	CFO	F — Tax withholding / forfeiture	929	$1.95	$2K	SEC
2026-04-01	Daniels Eric Joseph	Chief Development Officer	F — Tax withholding / forfeiture	929	$1.95	$2K	SEC
2026-04-01	Strem Brian M.	President and CEO	F — Tax withholding / forfeiture	1.9K	$1.95	$4K	SEC
2026-03-06	Daniels Eric Joseph	Chief Development Officer	A — Grant or award	6.5K	$0.00	—	SEC
2026-03-06	Strem Brian M.	President and CEO	A — Grant or award	16.7K	$0.00	—	SEC
2026-03-06	Tosca Melissa	CFO	A — Grant or award	6.5K	$0.00	—	SEC
2026-03-03	Daniels Eric Joseph	Chief Development Officer	F — Tax withholding / forfeiture	238	$2.02	$481	SEC
2026-03-03	Strem Brian M.	President and CEO	F — Tax withholding / forfeiture	238	$2.02	$481	SEC

All transactions sourced from SEC EDGAR Form 4 filings for KIORA PHARMACEUTICALS INC (KPRX). Updated in real time as new filings are submitted to the SEC.

Most-Active KPRX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Walters-Hoffert Lisa	1	—
TYLE PRAVEEN	1	—
Hollander David	1	—
Stengone Carmine N.	1	—
Strem Brian M.	1	$5K

Recent KPRX Form 8-K Material Events

2026-06-18 — Item 7.01, 9.01 [SEC]
2026-06-10 — Item 5.02, 5.07, 9.01 [SEC]
2026-05-08 — Item 2.02, 9.01 [SEC]
2026-04-07 — Item 1.01, 3.02, 7.01, 9.01 · Financing · neutral [SEC]
Kiora Pharmaceuticals completed a private placement on April 6, 2026, issuing common stock and warrants to institutional investors for approximately $5.0 million in gross proceeds, with potential additional proceeds of ~$19.0 million from warrant exercises. The offering includes
2026-04-02 — Item 5.02, 7.01, 9.01 · Leadership · neutral [SEC]
Eric J. Daniels, M.D., MBA, Chief Development Officer of Kiora Pharmaceuticals, resigned effective April 17, 2026, to pursue another opportunity. The resignation was not due to any disagreement with the company's operations, policies, or practices.

Recent Insider Filings

2026-07-02 — Tosca Melissa (CFO)
2026-07-02 — Strem Brian M. (President and CEO)
2026-06-12 — Stengone Carmine N. (Director)
2026-06-12 — Shapiro Aron (Director)
2026-06-12 — Parsons Erin (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in KPRX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

KPRX Insider Trading — FAQ

What is the latest insider trade for KPRX?: KIORA PHARMACEUTICALS INC (KPRX) had 8 insider filings in the last 90 days, with the most recent on 2026-07-02. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying KPRX stock?: 0 insider purchases of KPRX were filed in the last 90 days.
How many insiders are selling KPRX stock?: 0 insider sales of KPRX were filed in the last 90 days.
Where can I see KPRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every KPRX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live KPRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.